跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KADIAN morphine sulfate pentahydrate 20mg sustained release capsule bottle - TGA Drug Approval Details
Approvals
/
TGA
/
KADIAN morphine sulfate pentahydrate 20mg sustained release capsule bottle
Approved
STANDARD
KADIAN morphine sulfate pentahydrate 20mg sustained release capsule bottle
Mayne Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
6c02c8597aa14e47
Company
Mayne Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
6c02c8597aa14e47
Product Name
KADIAN morphine sulfate pentahydrate 20mg sustained release capsule bottle
Artg Id
56832
Artg Name
KADIAN morphine sulfate pentahydrate 20mg sustained release capsule bottle
Sponsor
Mayne Pharma International Pty Ltd
Company Detail Path
/organization/mayne-pharma-international-pty-ltd
Artg Date
1996-08-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
6c02c8597aa14e47
Type
Standard
Back to TGA Approvals
